CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 100 enrolled
Drug / intervention
Goal-directed therapydevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05964374
NCT05964374N/ACompleted
CompareCT.gov

Goal-Directed Therapy (GDT) Using Hypotension Prediction Index (HPI) Following Cardiac Surgery: a Pilot Randomized Control Trial

University of Calgary·interventional·Posted Jul 27, 2023·Updated May 14, 2026

In Brief

A clinical study evaluating Goal-directed therapy for Surgery. Completed, enrolled 100 participants across 1 site.

Detailed Summary

Pilot prospective randomized control trial comparing goal-directed therapy algorithm vs routine care in the intensive care unit following cardiac surgery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSurgery
CountriesCanada
CollaboratorsUniversity of Alberta

Timeline

N/ACompletedFinished
202420252026
First PostedJul 27, 2023
Enrollment StartNov 1, 2023
Primary CompletionAug 15, 2024
Study CompletionFeb 1, 2025
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 2.9 years ago

Interventions

Goal-directed therapydevice

Goal-directed therapy using HemoSphere® monitor, Acumen® transducer, and Hypotension Prediction Index® algorithm (Edwards Lifesciences, Irvine, USA),